celecoxib and apricoxib

celecoxib has been researched along with apricoxib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagsby, AL; Freiter, EM; Mandal, PK; McMurray, JS; Robertson, FM	1
Hirota, T; Ikeda, T; Inoue, S; Kawai, K; Koyama, K; Oitate, M	1
Bandy, DP; Daniels, SE; Desjardins, PJ; Lawson, JE; Link, AJ; Moberly, JB; Truitt, KE; Xu, J	1

Trials

1 trial(s) available for celecoxib and apricoxib

Article	Year
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. Clinical therapeutics, 2007, Volume: 29, Issue:3 Topics: Acute Disease; Adolescent; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Molar, Third; Pain Measurement; Pain, Postoperative; Pyrazoles; Pyrroles; Sulfonamides; Tooth Extraction; Tooth, Impacted; Treatment Outcome	2007

Article

Year

A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.

Clinical therapeutics, 2007, Volume: 29, Issue:3

Topics: Acute Disease; Adolescent; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Molar, Third; Pain Measurement; Pain, Postoperative; Pyrazoles; Pyrroles; Sulfonamides; Tooth Extraction; Tooth, Impacted; Treatment Outcome

2007

Other Studies

2 other study(ies) available for celecoxib and apricoxib

Article	Year
Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. Bioorganic & medicinal chemistry letters, 2011, Oct-15, Volume: 21, Issue:20 Topics: Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Inflammatory Breast Neoplasms; Pyrroles; Sulfonamides	2011
Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats. Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:8 Topics: Animals; Aorta, Thoracic; Carbon Radioisotopes; Celecoxib; Cyclooxygenase 2 Inhibitors; Elastin; Lactones; Male; Protein Binding; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones; Tissue Distribution	2006

Article

Year

Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.

Bioorganic & medicinal chemistry letters, 2011, Oct-15, Volume: 21, Issue:20

Topics: Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Inflammatory Breast Neoplasms; Pyrroles; Sulfonamides

2011

Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats.

Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:8

Topics: Animals; Aorta, Thoracic; Carbon Radioisotopes; Celecoxib; Cyclooxygenase 2 Inhibitors; Elastin; Lactones; Male; Protein Binding; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones; Tissue Distribution

2006